Xenon Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:XENE) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 798.14 M743.28 M674.28 M607.84 M633.16 M Total liabilities 43.24 M39.32 M40.3 M48.33 M51.4 M Total equity 754.9 M703.96 M633.98 M559.51 M581.76 M Total liabilities & shareholders' equities 798.14 M743.28 M674.28 M607.84 M633.16 M Total debt ————— Net debt —————

뉴스

Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why

제논 파마슈티컬 주가 목표가, Wedbush, 63달러로 하향 조정

Wedbush lowers Xenon Pharmaceuticals stock price target to $63

BofA, 제논 파마슈티컬스 목표가 상향…임상 성공에 힘입어

BofA raises Xenon Pharmaceuticals price target on trial success

제논 파마슈티컬스, 7억 4,750만 달러 규모 공모 완료

Xenon Pharmaceuticals closes $747.5M public offering

제논 파마슈티컬스, 주당 57달러에 6억 5천만 달러 규모 공모가 결정

Xenon Pharmaceuticals prices $650M public offering at $57/share

XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study

시티즌스, 랩포트 테라퓨틱스에 ’시장수익률 상회’ 투자의견 유지

Citizens reiterates Rapport Therapeutics stock rating on seizure drug potential